Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ipecac myopathy and cardiomyopathy

L P Dresser1, E W Massey, E E Johnson

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710.

Journal of Neurology, Neurosurgery, and Psychiatry
|May 1, 1993
PubMed
Summary

Ipecac abuse can cause severe muscle weakness (myopathy) and heart problems (cardiomyopathy) in young women with eating disorders. Symptoms improved after stopping ipecac use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives on the Low Demand Transitional Model in Engaging and Housing hard-to-reach Veterans Experiencing Unsheltered Homelessness.

Community mental health journal·2025
Same author

Proximity to a high traffic road: glucocorticoid and life history consequences for nestling white-crowned sparrows.

General and comparative endocrinology·2011
Same author

The permanently patent (P.P.) intravenous needle.

British journal of anaesthesia·2010
Same author

Towards a receptor for nocistatin?

British journal of pharmacology·2007
Same author

Sural neuropathy: etiologies and predisposing factors.

Muscle & nerve·2006
Same author

Magnetic resonance imaging of intramuscular myxoma with histological comparison and a review of the literature.

Skeletal radiology·2004

Area of Science:

  • Cardiology
  • Neurology
  • Toxicology

Background:

  • Ipecac syrup is commonly used for emesis but can be abused.
  • Eating disorders are associated with various medical complications.

Observation:

  • Two young women with eating disorders presented with diffuse muscle weakness.
  • Clinical and electromyographic findings suggested ipecac-induced myopathy.

Findings:

  • Muscle biopsies confirmed ipecac myopathy in both patients.
  • One patient exhibited significant cardiomyopathy with echocardiographic evidence.
  • Both myopathy and cardiomyopathy resolved after ipecac cessation.

Implications:

  • This highlights the potential cardiotoxic and myotoxic effects of chronic ipecac abuse.
  • Early recognition and discontinuation of ipecac are crucial for recovery.
  • Awareness among clinicians is vital for diagnosing and managing ipecac-related complications.

Related Experiment Videos